These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 7230162

  • 1. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis.
    Lang AE, Humphrey JG, Gordn DA.
    J Rheumatol; 1981; 8(2):303-7. PubMed ID: 7230162
    [Abstract] [Full Text] [Related]

  • 2. [D-penicillamine-induced myasthenia gravis].
    Frey RA, Keller F, Michel BA.
    Schweiz Med Wochenschr; 1994 May 21; 124(20):852-6. PubMed ID: 8209208
    [Abstract] [Full Text] [Related]

  • 3. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
    Liu GT, Bienfang DC.
    J Clin Neuroophthalmol; 1990 Sep 21; 10(3):201-5. PubMed ID: 2144538
    [Abstract] [Full Text] [Related]

  • 4. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O, Hamelin JP, Rossard A, Cottin S, Cler JM, Rodat G, Lemouroux P.
    Nouv Presse Med; 1981 May 02; 10(20):1645-8. PubMed ID: 7255126
    [Abstract] [Full Text] [Related]

  • 5. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.
    Bucknall RC, Dixon A St J, Glick EN, Woodland J, Zutshi DW.
    Br Med J; 1975 Mar 15; 1(5958):600-2. PubMed ID: 1125624
    [Abstract] [Full Text] [Related]

  • 6. [Penicillamine-induced myasthenia gravis].
    Nishida H, Sahashi K.
    Ryoikibetsu Shokogun Shirizu; 2001 Mar 15; (36):351-3. PubMed ID: 11596408
    [No Abstract] [Full Text] [Related]

  • 7. D-penicillamine and the ocular myasthenic syndrome.
    Kimbrough RL, Mewis L, Stewart RH.
    Ann Ophthalmol; 1981 Oct 15; 13(10):1171-2. PubMed ID: 7316342
    [Abstract] [Full Text] [Related]

  • 8. [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].
    Seitz D, Hopf HC, Janzen RW, Meyer W.
    Dtsch Med Wochenschr; 1976 Jul 30; 101(31):1153-8. PubMed ID: 976101
    [Abstract] [Full Text] [Related]

  • 9. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A, Newsom-Davis J.
    Clin Exp Immunol; 1982 Aug 30; 49(2):266-72. PubMed ID: 7127905
    [Abstract] [Full Text] [Related]

  • 10. [Neuromuscular complications of D-penicillamine in rheumatoid arthritis].
    Dubost JJ, Soubrier M, Bouchet F, Kemeny JL, Lhopitaux R, Bussière JL, Sauvezie B.
    Rev Neurol (Paris); 1992 Aug 30; 148(3):207-11. PubMed ID: 1604135
    [Abstract] [Full Text] [Related]

  • 11. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ, Will RK, Peter JB, Garlepp MJ, Dawkins RL.
    J Rheumatol; 1987 Oct 30; 14(5):995-1001. PubMed ID: 3501473
    [Abstract] [Full Text] [Related]

  • 12. [Fundamental studies with respect to plasma exchange by using continuous-flow centrifuge system and the clinical trial in patients with myasthenia gravis].
    Suga M, Akahonai Y, Tsujisaki M, Mori M, Yoshizaki H, Matsumoto H, Yachi A.
    Hokkaido Igaku Zasshi; 1982 Nov 30; 57(6):734-40. PubMed ID: 7183499
    [Abstract] [Full Text] [Related]

  • 13. D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
    Fawcett PR, McLachlan SM, Nicholson LV, Argov Z, Mastaglia FL.
    Muscle Nerve; 1982 Apr 30; 5(4):328-34. PubMed ID: 7099199
    [Abstract] [Full Text] [Related]

  • 14. Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.
    Tzartos SJ, Morel E, Efthimiadis A, Bustarret AF, D'Anglejan J, Drosos AA, Moutsopoulos HA.
    Clin Exp Immunol; 1988 Oct 30; 74(1):80-6. PubMed ID: 2464451
    [Abstract] [Full Text] [Related]

  • 15. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G, Maida EM.
    Z Rheumatol; 1986 Oct 30; 45(3):118-21. PubMed ID: 3751350
    [Abstract] [Full Text] [Related]

  • 16. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
    Raynauld JP, Lee YS, Kornfeld P, Fries JF.
    J Rheumatol; 1993 Sep 30; 20(9):1592-3. PubMed ID: 8164222
    [Abstract] [Full Text] [Related]

  • 17. The pathophysiology of penicillamine-induced myasthenia gravis.
    Kuncl RW, Pestronk A, Drachman DB, Rechthand E.
    Ann Neurol; 1986 Dec 30; 20(6):740-4. PubMed ID: 3813503
    [Abstract] [Full Text] [Related]

  • 18. D-penicillamine induced myasthenia gravis: clinical, serological and genetic findings.
    Drosos AA, Christou L, Galanopoulou V, Tzioufas AG, Tsiakou EK.
    Clin Exp Rheumatol; 1993 Dec 30; 11(4):387-91. PubMed ID: 8403583
    [Abstract] [Full Text] [Related]

  • 19. Myasthenia gravis and D-penicillamine.
    Dawkins RL, Garlepp MJ, McDonald BL, Williamson J, Zilko PJ, Carrano J.
    J Rheumatol Suppl; 1981 Dec 30; 7():169-74. PubMed ID: 7014873
    [Abstract] [Full Text] [Related]

  • 20. Management of myasthenia gravis.
    Schwendimann RN, Burton E, Minagar A.
    Am J Ther; 2005 Dec 30; 12(3):262-8. PubMed ID: 15891271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.